| Literature DB >> 17220782 |
Tatsuya Kin1, Paul R V Johnson, A M James Shapiro, Jonathan R T Lakey.
Abstract
Substantial advances in human islet isolation technology have occurred during the past decade. However, it is still difficult to recover the entire quantity of islets contained in a pancreas. A major obstacle to successful human islet isolation has been the variability of the collagenase digestion phase of islet isolation. Future advances in enzyme technology will make it possible to optimally liberate islets with enzyme blends "tailor-made" for each individual donor pancreas. Such innovative strategies will be advantageous in improving islet isolation efficiency, recovery, viability, and ultimately posttransplant function.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17220782 DOI: 10.1097/01.tp.0000243169.09644.e6
Source DB: PubMed Journal: Transplantation ISSN: 0041-1337 Impact factor: 4.939